HALIX
Djamel Deken is a seasoned professional in business development with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Director of Business Development at HALIX since March 2023, Djamel previously held the position of Head of Business Development at Wacker Biotech B.V., where responsibilities included managing the Business Development team and securing significant contract manufacturing projects across Germany and the Netherlands. Prior to Wacker Biotech, Djamel was a Manager of Business Development at OctoPlus and started a career as a Market Research Analyst. Djamel holds a Master of Science in Pharmaceutical Sciences from Vrije Universiteit Amsterdam, obtained in 2005.
HALIX
HALIX is a fast growing, biopharmaceutical contract development and manufacturing organization (CDMO) focused on viral vector and recombinant protein products. We have recently built a state-of-the-art GMP manufacturing facility at the Bio Science Park in Leiden that is getting filled with exciting new vaccines, antibodies and protein products. At HALIX, we support our customers with the development & commercialization of biologics enabling the treatment & prevention of life threatening conditions such as cancer, COVID-19, influenza and other infectious diseases. Currently we are working on the production of a leading COVID-19 vaccine candidate. If you too would like to contribute to this challenging and fulfilling activity, becoming part of an inspiring biotech services company, then this is a perfect opportunity for you!